Competition & Peer Data API & CSV Delivery

Xg Sciences Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Xg Sciences Inc (XGSCI) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2020
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
59.63 %
Q4 2020
Net Margin
-511.82 %
Q4 2020

Key Findings: Xg Sciences Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 1M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+15.8% annualized vs trailing 12 months).
  • Peer revenue share: Xg Sciences Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

XGSCI Sales vs. its Competitors, Q4 2020

Xg Sciences Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/XGSCI/competitors
https://api.csimarket.com/api/v1/companies/XGSCI/relationships
https://api.csimarket.com/api/v1/companies/XGSCI/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Chemicals - Plastics & Rubber industry grew revenue -4.6% year over year, combined, vs 59.6% for Xg Sciences Inc. Xg Sciences Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

Xg Sciences Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Xg Sciences Inc No No No No
Similar Growth & Profitability (8) 62.50 % (5 of 8) 50.00 % (4 of 8) 50.00 % (4 of 8) 28.60 % (2 of 7)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2020

100%market share
  • Xg Sciences Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Xg Sciences Inc and its 0 tracked competitors.

See Xg Sciences Inc's full market share breakdown »

XGSCI Stock Performance relative to its Competitors

XGSCI Competitors (weighted) Percent change over the selected range

XGSCI Stock Performance relative to Similar Growth & Profitability Competitors

XGSCI Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Xg Sciences Inc's Comment on Competition and Industry Peers

The Company operates in a market that is expected to have significant competition in the future. Global research is being conducted by substantially larger companies who have greater financial, personnel, technical, and marketing resources. There can be no assurance that our strategy of offering better materials based on our proprietary exfoliated graphite nanoplatelets will be able to compete with other companies, many of whom will have significantly greater resources, on a continuing basis. In the event that we cannot compete successfully, we may be forced to cease operations and investors may lose all or a significant part of their investment.